429 related articles for article (PubMed ID: 30579238)
1. Liquid biopsy: miRNA as a potential biomarker in oral cancer.
Mazumder S; Datta S; Ray JG; Chaudhuri K; Chatterjee R
Cancer Epidemiol; 2019 Feb; 58():137-145. PubMed ID: 30579238
[TBL] [Abstract][Full Text] [Related]
2. Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma.
Singh P; Srivastava AN; Sharma R; Mateen S; Shukla B; Singh A; Chandel S
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1053-1057. PubMed ID: 29699056
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
4. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy.
Rapado-González Ó; López-López R; López-Cedrún JL; Triana-Martínez G; Muinelo-Romay L; Suárez-Cunqueiro MM
Cells; 2019 Dec; 8(12):. PubMed ID: 31861130
[TBL] [Abstract][Full Text] [Related]
5. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic implications of miRNAs in Liquid Biopsy for Oral Squamous Cell Carcinoma (OSCC): Clinical validity and interpretation.
Jayaraj R; Kumaraswamy C; Raymond G; Ravishankar Ram M; Govind SK; Chandramoorthy HC; Shaw P
Oral Oncol; 2020 Oct; 109():104634. PubMed ID: 32171663
[No Abstract] [Full Text] [Related]
7. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
[TBL] [Abstract][Full Text] [Related]
8. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma.
Chen L; Hu J; Pan L; Yin X; Wang Q; Chen H
Cancer Biomark; 2018; 23(3):333-339. PubMed ID: 30223386
[TBL] [Abstract][Full Text] [Related]
10. miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma.
Sun G; Cao Y; Wang P; Song H; Bie T; Li M; Huai D
Biomarkers; 2018 Mar; 23(2):137-141. PubMed ID: 28135849
[TBL] [Abstract][Full Text] [Related]
11. Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma.
Shi J; Bao X; Liu Z; Zhang Z; Chen W; Xu Q
Theranostics; 2019; 9(4):920-931. PubMed ID: 30867806
[TBL] [Abstract][Full Text] [Related]
12. A circulating microRNA panel as a novel dynamic monitor for oral squamous cell carcinoma.
Piao Y; Jung SN; Lim MA; Oh C; Jin YL; Kim HJ; Nguyen QK; Chang JW; Won HR; Koo BS
Sci Rep; 2023 Feb; 13(1):2000. PubMed ID: 36737651
[TBL] [Abstract][Full Text] [Related]
13. Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study.
Nakashima H; Yoshida R; Hirosue A; Kawahara K; Sakata J; Arita H; Yamamoto T; Toya R; Murakami R; Hiraki A; Shinohara M; Ito T; Kuwahara Y; Nakayama H
Tumour Biol; 2019 Mar; 41(3):1010428319826853. PubMed ID: 30887897
[TBL] [Abstract][Full Text] [Related]
14. A Three-MicroRNA Signature as a Potential Biomarker for the Early Detection of Oral Cancer.
Chang YA; Weng SL; Yang SF; Chou CH; Huang WC; Tu SJ; Chang TH; Huang CN; Jong YJ; Huang HD
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518940
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-223 in Oral Cancer: Its Potential as a Novel Diagnostic Biomarker and Therapeutic Target.
Tachibana H; Sho R; Takeda Y; Zhang X; Yoshida Y; Narimatsu H; Otani K; Ishikawa S; Fukao A; Asao H; Iino M
PLoS One; 2016; 11(7):e0159693. PubMed ID: 27441818
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of miRNAs in the serum of patients with high-risk oral lesions.
Maclellan SA; Lawson J; Baik J; Guillaud M; Poh CF; Garnis C
Cancer Med; 2012 Oct; 1(2):268-74. PubMed ID: 23342275
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma.
Ren W; Qiang C; Gao L; Li SM; Zhang LM; Wang XL; Dong JW; Chen C; Liu CY; Zhi KQ
Biomarkers; 2014 Nov; 19(7):590-6. PubMed ID: 25174622
[TBL] [Abstract][Full Text] [Related]
18. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
Gai C; Camussi F; Broccoletti R; Gambino A; Cabras M; Molinaro L; Carossa S; Camussi G; Arduino PG
BMC Cancer; 2018 Apr; 18(1):439. PubMed ID: 29669525
[TBL] [Abstract][Full Text] [Related]
19. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of altered miRNA expression in whole blood of OSCC patients.
Ries J; Baran C; Wehrhan F; Weber M; Neukam FW; Krautheim-Zenk A; Nkenke E
Oncol Rep; 2017 Jun; 37(6):3467-3474. PubMed ID: 28498442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
